Erectile dysfunction is common after a radical prostatectomy and newer techniques minimize this risk. Experienced surgeons now report recovery rates of satisfactory intercourse of 60-85% in their patients. Advancing age increases the risk of this complication. Multiple interventions can be effective and there is often slow recovery of function over time.
Oral PDE-5 inhibitors are usually the first line therapy, with reported efficacy in 10-80% of men after nerve sparing surgery, but probably below 15% after non-nerve sparing surgery. Second line therapies include intraurethral medications, intracavernosal injections and vacuum constriction devices, which should restore erectile function to most men.
Arthur L. Burnett, Erectile Dysfunction Following Radical Prostatectomy
Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL. Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy. Eur Urol. 2004 45:123-133.
A. Segal, A. L, Burnett, Erectile preservation following radical prostatectomy Therapeutic Advances in Urology. 2011;3(1):35-46.
ARTHUR L. BURNETT Molecular Pharmacotherapeutic Targeting of PDE5 for Preservation of Penile Health Journal of Andrology, Vol. 29, No. 1, January/February 2008